G.A. Ricaurte

4.7k total citations · 1 hit paper
38 papers, 3.8k citations indexed

About

G.A. Ricaurte is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Clinical Psychology. According to data from OpenAlex, G.A. Ricaurte has authored 38 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cellular and Molecular Neuroscience, 9 papers in Molecular Biology and 9 papers in Clinical Psychology. Recurrent topics in G.A. Ricaurte's work include Neurotransmitter Receptor Influence on Behavior (25 papers), Neuroscience and Neuropharmacology Research (17 papers) and Psychedelics and Drug Studies (9 papers). G.A. Ricaurte is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (25 papers), Neuroscience and Neuropharmacology Research (17 papers) and Psychedelics and Drug Studies (9 papers). G.A. Ricaurte collaborates with scholars based in United States, Russia and Denmark. G.A. Ricaurte's co-authors include Lewis S. Seiden, Charles R. Schuster, Karen E. Sabol, Ian Irwin, L.E. DeLanney, Jonathan L. Katz, R. W. Guillery, J. William Langston, R.Y. Moore and J. William Langston and has published in prestigious journals such as Science, The Lancet and JAMA.

In The Last Decade

G.A. Ricaurte

38 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amphetamine: Effects on Catecholamine Systems and Behavior

1993 690 citations Lewis S. Seiden, Karen E. Sabol et al. The Annual Review of Pharmacology and Toxicology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G.A. Ricaurte United States	27	3.0k	1.4k	1.0k	796	705	38	3.8k
M J Kuhar United States	35	3.5k 1.2×	421 0.3×	290 0.3×	347 0.4×	2.2k 3.1×	56	4.8k
E B De Souza United States	25	2.0k 0.7×	434 0.3×	346 0.3×	349 0.4×	1.1k 1.6×	52	4.3k
Mary C. Ritz United States	23	3.8k 1.3×	449 0.3×	209 0.2×	386 0.5×	2.2k 3.2×	40	4.5k
Karen E. Sabol United States	19	1.4k 0.5×	370 0.3×	287 0.3×	257 0.3×	451 0.6×	33	1.9k
G L Gessa Italy	34	2.5k 0.9×	278 0.2×	149 0.1×	409 0.5×	985 1.4×	61	3.5k
G. L. Gessa Italy	38	3.3k 1.1×	339 0.2×	204 0.2×	646 0.8×	1.6k 2.3×	99	5.0k
Joanna S. Fowler United States	15	1.5k 0.5×	287 0.2×	163 0.2×	305 0.4×	466 0.7×	18	2.2k
George Battaglia United States	29	1.6k 0.6×	409 0.3×	472 0.5×	307 0.4×	840 1.2×	64	2.6k
MJ Kuhar United States	16	1.9k 0.7×	270 0.2×	201 0.2×	210 0.3×	959 1.4×	22	2.8k
Robert Hitzemann United States	7	1.5k 0.5×	300 0.2×	173 0.2×	265 0.3×	436 0.6×	8	2.0k

Countries citing papers authored by G.A. Ricaurte

Since Specialization

Citations

This map shows the geographic impact of G.A. Ricaurte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.A. Ricaurte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.A. Ricaurte more than expected).

Fields of papers citing papers by G.A. Ricaurte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.A. Ricaurte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.A. Ricaurte. The network helps show where G.A. Ricaurte may publish in the future.

Co-authorship network of co-authors of G.A. Ricaurte

This figure shows the co-authorship network connecting the top 25 collaborators of G.A. Ricaurte. A scholar is included among the top collaborators of G.A. Ricaurte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.A. Ricaurte. G.A. Ricaurte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peters, Frank T., et al.. (2008). Liquid chromatographic–electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxymethamphetamine in rat brain. Journal of Chromatography B. 874(1-2). 119–124. 9 indexed citations

Ricaurte, G.A., U. McCann, Z Szabò, & Ursula Scheffel. (2000). Toxicodynamics and long-term toxicity of the recreational drug, 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’). Toxicology Letters. 112-113. 143–146. 90 indexed citations

Wong, Dean F., G.A. Ricaurte, Gerhard Gründer, et al.. (1997). Dopamine Transporter Changes in Neuropsychiatric Disorders. Advances in pharmacology. 42. 219–223. 20 indexed citations

Yuan, Jie, et al.. (1996). Neurotoxic and pharmacologic studies on enantiomers of the N-methylated analog of cathinone (methcathinone): a new drug of abuse.. Journal of Pharmacology and Experimental Therapeutics. 279(2). 1043–1052. 57 indexed citations

Seiden, Lewis S., Karen E. Sabol, & G.A. Ricaurte. (1993). Amphetamine: Effects on Catecholamine Systems and Behavior. The Annual Review of Pharmacology and Toxicology. 33(1). 639–676. 690 indexed citations breakdown →

Scanzello, Carla R., George Hatzidimitriou, Alessandra Martello, Jonathan L. Katz, & G.A. Ricaurte. (1993). Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine injury: observations in rats.. Journal of Pharmacology and Experimental Therapeutics. 264(3). 1484–1491. 99 indexed citations

Ricaurte, G.A., et al.. (1993). 3,4-Methylenedioxymethamphetamine, serotonin and memory.. Journal of Pharmacology and Experimental Therapeutics. 266(2). 1097–1105. 60 indexed citations

Ricaurte, G.A., et al.. (1992). Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations.. Journal of Pharmacology and Experimental Therapeutics. 261(2). 616–622. 187 indexed citations

Ricaurte, G.A., et al.. (1991). Dexfenfluramine neurotoxicity in brains of non-human primates. The Lancet. 338(8781). 1487–1488. 63 indexed citations

10.

Ricaurte, G.A., Kevin T. Finnegan, Ian Irwin, & J. William Langston. (1990). Aminergic Metabolites in Cerebrospinal Fluid of Humans Previously Exposed to MDMA: Preliminary Observations^a. Annals of the New York Academy of Sciences. 600(1). 699–708. 78 indexed citations

11.

Witkin, Jeffrey M., G.A. Ricaurte, & Jonathan L. Katz. (1990). Behavioral effects of N-methylamphetamine and N,N-dimethylamphetamine in rats and squirrel monkeys.. Journal of Pharmacology and Experimental Therapeutics. 253(2). 466–474. 14 indexed citations

12.

Ricaurte, G.A., et al.. (1989). Chronic idiopathic ataxic neuropathy: neuropathology of a case. Acta Neuropathologica. 79(1). 104–107. 12 indexed citations

13.

Ricaurte, G.A., L.E. DeLanney, Ian Irwin, et al.. (1989). Evaluation of the neurotoxic potential of N,N-dimethylamphetamine: an illicit analog of methamphetamine. Brain Research. 490(2). 301–306. 15 indexed citations

14.

Ricaurte, G.A.. (1989). Studies of MDMA-Induced Neurotoxicity in Nonhuman Primates: A Basis for Evaluating Long-Term Effects in Humans. PsycEXTRA Dataset. 94. 306–22. 23 indexed citations

15.

Ricaurte, G.A., L.E. DeLanney, Sandra G. Wiener, Ian Irwin, & J. William Langston. (1988). 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates. Brain Research. 474(2). 359–363. 73 indexed citations

16.

Ricaurte, G.A., L.E. DeLanney, Kevin T. Finnegan, Ian Irwin, & J. William Langston. (1988). The dopamine-depleting effect of 6-hydroxydopamine does not increase with aging. Brain Research. 438(1-2). 395–398. 10 indexed citations

17.

Ricaurte, G.A., L.E. DeLanney, Ian Irwin, & J. William Langston. (1988). Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Research. 446(1). 165–168. 184 indexed citations

18.

Finnegan, Kevin T., G.A. Ricaurte, Lorrene D. Ritchie, et al.. (1988). Orally administered MDMA causes a long-term depletion of serotonin in rat brain. Brain Research. 447(1). 141–144. 38 indexed citations

19.

Finnegan, Kevin T., Ian Irwin, L.E. DeLanney, G.A. Ricaurte, & J. William Langston. (1987). 1,2,3,6-tetrahydro-1-methyl-4-(methylpyrrol-2-yl)pyridine: studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.. Journal of Pharmacology and Experimental Therapeutics. 242(3). 1144–1151. 18 indexed citations

20.

Forno, Lysia S., et al.. (1986). ULTRASTRUCTURE OF NERVE CELL DEGENERATION IN THE SUBSTANTIA NIGRA IN EXPERIMENTAL MPTP-INDUCED PARKINSONISM IN THE MOUSE AND IN THE SQUIRREL MONKEY. Journal of Neuropathology & Experimental Neurology. 45(3). 376–376. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact